Table 2

- Demographic and clinical characteristics of subjects (N=105).

Characteristicsn (%)
Age
1-209 (8.6)
21-4047 (44.8)
41-6025 (23.8)
61-9024 (22.9)
Mean42.93
Median x-bar38.00
Standard deviation21.329
Gender
Male68 (64.8)
Female37 (35.2)
Nationality
Saudi85 (81.0)
Non-Saudi19 (18.1)
Not mentioned1 (0.9)
Comorbidities
Diabetes mellitus28 (26.7)
Hypertension22 (21.0)
Ischemic heart disease8 (7.6)
Human immunodeficiency virus1 (0.95)
Malignancy7 (6.7)
Immunosuppression5 (4.8)
Other comorbidities30 (28.6)
No comorbidities50 (47.6)
Previous treatment for tuberculosis
Yes6 (5.7)
No99 (94.3)
Site of infection
Unknown6 (5.7)
Pulmonary39 (37.1)
Extrapulmonary34 (32.4)
Disseminated*26 (24.8)
  • Values are presented as numbers and percentages (%).

  • * Disseminated infection involves both the pulmonary and extrapulmonary systems. HIV: Human immunodeficiency virus